NeilMed launches Naspira nasal-oral aspirator
NeilMed Pharmaceuticals Inc. USA has rolled out the Naspira nasal-oral aspirator for babies and small children.
NeilMed Pharmaceuticals Inc. USA has rolled out the Naspira nasal-oral aspirator for babies and small children.
Perrigo Co. plc has acquired the ScarAway scar management brand from Enaltus LLC. Financial terms of the transaction weren’t disclosed. Perrigo said Monday that Scaraway is expected to generate overall 2015 net sales of $10 million, or approximately $3 million for the remainder of the year.
Care Pharmacies Cooperative Inc. has extended the contract of chief executive officer Michael Wysong.
Early feedback on the Food and Drug Administration’s proposal on naming conventions for biosimilars shows a mixed response.
Head & Shoulders has signed up New York Giants wide receiver Odell Beckham as its latest hair ambassador. The Procter & Gamble hair care brand — the official shampoo of the National Football League — said Friday that fans can now see Beckham in his first ad for Head & Shoulders on the
Johnson & Johnson and Procter & Gamble — are involved in collaborations that could make a big impact in fighting flu and heart disease. Scientists from The Scripps Research Institute (TSRI) and J&J’s Janssen pharmaceutical subsidiary have found a way to induce antibodies to fight a wide range
Novo Nordisk plans to acquire Calibrium LLC and MB2 LLC, two privately held biopharmaceutical research companies based in Carmel, Ind.
Beauty care manufacturer and distributor American International Industries (A.I.I.) has acquired Hollywood Fashion Secrets, a brand of fashion and beauty accessories. Financial terms of the agreement, announced Thursday, weren’t disclosed.
Aurobindo Pharma Ltd. has gained approval from the Food and Drug Administration for entecavir tablets 0.5 mg and 1 mg, a medication for hepatitis B. Aurobindo, which announced the product this week, said its entecavir tablets are a generic version of Baraclude tablets (0.
The National Association of Chain Drug Stores reported that the consensus of attendees at the 2015 NACDS Total Store Expo is clear: This year’s conference was a rewarding experience. NACDS said there was a tangible energy reverberating throughout the event, held Aug.
Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Co. have received approval from the Food and Drug Administration for Synjardy tablets, a medication for type 2 diabetes.
CVS Health has formed new clinical affiliations with St. Luke’s University Health Network in Bethlehem, Pa., and TriHealth in Cincinnati.
Alvogen has entered an agreement to buy a portfolio of four U.S. pharmaceutical products from Pfizer Inc. Under the deal announced Wednesday, Alvogen plans to acquire three injectable products — Clindamycin, Voriconazole and Melphalan — and one inhaled solution product, Acetylcysteine.
Heartland Food Products Group plans to acquire the Splenda low-calorie sweetener brand from McNeil Nutritionals LLC, a subsidiary of Johnson & Johnson Consumer Inc. Financial terms of the agreement weren’t disclosed. Heartland said the transaction is slated to close before the end of this year.
National drug chains are working hard to drive more sales in the beauty care category. The merged Walgreens Boots Alliance Inc., for starters, is revamping its stores with a swankier cosmetics offering centered on the Boots No7 skin care line, which already drives traffic across Europe.
Too many people still don’t feel the need to get a flu shot, a new survey from Kmart Pharmacy finds. Of more than 10,000 U.S. adults polled online, 41% said they typically don’t get a flu shot — even though 94% agree some people are particularly vulnerable to getting the flu